Consortium International Holdings, LLC (CIH) is a USA based entity with over 22 years of combined experience in infectious diseases. Through the experience and relationships developed and maintained internationally, CIH has entered into the fight against Covid-19 providing high quality SARS CoV-2 (Covid-19) testing technologies with highly sensitive, specific and reliable rapid diagnostic tests. Product lines include Covid-19 Antigen Covid-19 Antigen, Covid-19 Antibody IgG/IgM Rapid tests as well as new SARS-CoV-2 plus Influenza A/B Antigen Rapid tests.
Consortium International is also introducing a new, semi-quantitative Neutralizing Antibody test only available to those markets outside of the USA. CIH also has offers a series of highly competitive Real-Time PCRs for the detection of 2019 SARS CoV-2 and which also includes the newly announced SARS-CoV-2 & Influenza A/B Nucleic Acid Detection Kit.
CIH offers the INDICAID Covid-19 Antigen Rapid Test which carries the US FDA EUA POC and the HEALGEN Covid-19 Antibody IgG/IgM Rapid test has the US FDA EUA. In addition CIH offers the HEALGEN Covid-19 Antigen Rapid Test which is not available for distribution in the USA and are clearly noted.
We invite you to view our product lists and determine those testing products that will best meet your requirements. Our goal is to work with you and your staff to deliver quality products, proven to perform and that deliver reliable and repeatable results. Those products that have received the US FDA EUA are properly identified. Products selected and accepted in our CIH product line are based upon their quality, reliability and performance.
For more information contact:
Consortium International Holdings
Miami Beach, Florida, 33139 USA
Phone: +1.305.978.4590 Fax: +1.305.437.8120